Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate (LTBL) syndrome is a rare, genetic neurological disorder defined by early-onset of neurologic symptoms, biphasic clinical course, unique MRI features (incl. extensive, symmetrical, deep white matter abnormalities), and increased lactate in body fluids. The severe form is characterized by delayed psychomotor development, seizures, early-onset hypotonia, and persistently increased lactate levels. The mild form usually presents with irritability, psychomotor regression after six months of age, and temporary high lactate levels, with overall clinical improvement from the second year onward.
Features include always present findings: Poor head control, Low muscle tone (hypotonia), Elevated circulating alanine aminotransferase concentration, and Elevated circulating alpha-fetoprotein concentration and others; and very common findings: Delayed CNS myelination, Loss of previously acquired skills (developmental regression), and Global developmental delay. 35 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 9 | Slowness of movement (bradykinesia), Dystonia, Seizure |
Lab test results | 7 | Elevated circulating alanine aminotransferase concentration, Elevated circulating alpha-fetoprotein concentration, Elevated circulating aspartate aminotransferase concentration |
Digestive system | 4 | Cholestasis, Enlarged liver (hepatomegaly), Macrovesicular hepatic steatosis |
Muscles | 4 | Low muscle tone (hypotonia), Axial hypotonia, Ragged-red muscle fibers |
Eyes | 2 | Ptosis, Visual impairment |
Growth and development | 1 | Failure to thrive |
Head and neck | 1 | Cleft palate |
Pregnancy and birth | 1 | Neonatal hypotonia |
EARS2 encodes glutamyl-tRNA synthetase 2, mitochondrial (523 aa). Non-discriminating glutamyl-tRNA synthetase that catalyzes aminoacylation of both mitochondrial tRNA(Glu) and tRNA(Gln) and participates in RNA aminoacylation for mitochondrial protein translation. Highest expression in Cells EBV-transformed lymphocytes (22.1 TPM) and Cells Cultured fibroblasts (20.7 TPM).
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome is associated with mutations in the EARS2 gene on chromosome 16.
EARS2 is classified as a druggable target (Druggable Genome and Enzyme categories) with score 0.0.
Genetic testing for EARS2 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 9 always present features, 3 very common features, 6 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome.
18 publications have been identified in PubMed for leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome. Research spans Case Report / Case Series (56%), Basic Science / Preclinical (33%), and Review / Meta-Analysis (6%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 56% |
Laboratory research | 6 | 33% |
Research summaries | 1 | 6% |
Disease patterns and progression | 1 | 6% |
Alam MS (2026). [PMID: 41953407](https://pubmed.ncbi.nlm.nih.gov/41953407/). *Qatar Med J*. [Case Report / Case Series]
Mehta Y (2026). [PMID: 41880024](https://pubmed.ncbi.nlm.nih.gov/41880024/). *Cell Tissue Res*. [Basic Science / Preclinical]
Jiang H (2026). [PMID: 41915781](https://pubmed.ncbi.nlm.nih.gov/41915781/). *ACS Appl Bio Mater*. [Basic Science / Preclinical]
McManus MJ (2026). [PMID: 41704780](https://pubmed.ncbi.nlm.nih.gov/41704780/). *iScience*. [Basic Science / Preclinical]
Treitel R (2025). [PMID: 40344499](https://pubmed.ncbi.nlm.nih.gov/40344499/). *Am J Med Genet A*. [Case Report / Case Series]
Pervaiz I (2025). [PMID: 39807611](https://pubmed.ncbi.nlm.nih.gov/39807611/). *J Cell Physiol*. [Basic Science / Preclinical]
Bahar Ister M (2025). [PMID: 40176842](https://pubmed.ncbi.nlm.nih.gov/40176842/). *Mol Syndromol*. [Case Report / Case Series]
Radder S (2025). [PMID: 41357011](https://pubmed.ncbi.nlm.nih.gov/41357011/). *Cureus*. [Case Report / Case Series]
Haschke AM (2025). [PMID: 40367733](https://pubmed.ncbi.nlm.nih.gov/40367733/). *Stem Cell Res*. [Case Report / Case Series]
Sobeh T (2025). [PMID: 40637848](https://pubmed.ncbi.nlm.nih.gov/40637848/). *Neuroradiology*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 5:38 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center